Posted in | News | Lithium | Mining Business

Piedmont’s Partner Atlantic Lithium Announces Completion of Mineral Resource Estimate Update for Ewoyaa Project

Piedmont Lithium Inc. ("Piedmont" or the "Company"), a leading, diversified developer of lithium resources required to enable the U.S. electric vehicle supply chain, today announced that Piedmont's partner, Atlantic Lithium (AIM: ALL), recently announced completion of a Mineral Resource estimate update for the Ewoyaa Project in Cape Coast, Ghana totaling 30.1 million metric tonnes @ 1.26% Li2O.

Piedmont has an earn-in right to a 50% interest in Atlantic Lithium's Ghanaian projects including Ewoyaa and the Company holds an equity interest of approximately 10% in Atlantic Lithium. The updated Mineral Resource estimate, including 20.5 Mt @ 1.29% Li2O of Indicated Resources, was reported in accordance with JORC Code (2012) standards.

"We're very pleased with the reported increase in Mineral Resources for the Ewoyaa Project, notably the increase in Mineral Resources in the Indicated category" said Piedmont's Chief Operating Officer, Patrick Brindle. Mr. Brindle added, "The Ewoyaa Project is one of the best located spodumene project in Africa, and its development is fundamental to our growth strategy as an important source of spodumene concentrate for our LHP-2 Project. We look forward to Atlantic Lithium's completion of a prefeasibility study for the Ewoyaa Project, which will both increase the level of engineering definition for the Project as well as provide important data needed to advance regulatory approvals for the Project."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.